Frederic Guerard

CIK: 0001825009

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)8 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CALC

CalciMedica, Inc.

Director

LENZ

LENZ Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

CALC
CalciMedica, Inc.
Oct 1, 2026
Award(A)
Director Stock Option (Right to Buy)
Direct
20K shares-
CALC
CalciMedica, Inc.
Aug 19, 2026
Award(A)
Director Stock Option (Right to Buy)
Direct
10K shares-
LENZ
LENZ Therapeutics, Inc.
Jun 15, 2026
Award(A)
Stock Option (right to buy)
Direct
22.1K shares-
CALC
CalciMedica, Inc.
Jun 24, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
15K shares-
CALC
CalciMedica, Inc.
Jun 24, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
10K shares-
CALC
CalciMedica, Inc.
Jun 24, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
10K shares-
CALC
CalciMedica, Inc.
Jun 24, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
5K shares-
LENZ
LENZ Therapeutics, Inc.
Jun 11, 2025
Award(A)
Stock Option (right to buy)
Direct
13.5K shares-

		Type	Shares	Price		Ownership
Oct 1, 2026	CALC CalciMedica, Inc.	Award(A) Director Stock Option (Right to Buy)	20,000	-	-	Direct
Aug 19, 2026	CALC CalciMedica, Inc.	Award(A) Director Stock Option (Right to Buy)	10,000	-	-	Direct
Jun 15, 2026	LENZ LENZ Therapeutics, Inc.	Award(A) Stock Option (right to buy)	22,100	-	-	Direct
Jun 24, 2025	CALC CalciMedica, Inc.	Award(A) Director Stock Option (Right to Buy)	15,000	-	-	Direct
Jun 24, 2025	CALC CalciMedica, Inc.	Award(A) Director Stock Option (Right to Buy)	10,000	-	-	Direct
Jun 24, 2025	CALC CalciMedica, Inc.	Award(A) Director Stock Option (Right to Buy)	10,000	-	-	Direct
Jun 24, 2025	CALC CalciMedica, Inc.	Award(A) Director Stock Option (Right to Buy)	5,000	-	-	Direct
Jun 11, 2025	LENZ LENZ Therapeutics, Inc.	Award(A) Stock Option (right to buy)	13,500	-	-	Direct

1-8 of 8 transactions

About Guerard Frederic

Guerard Frederic (SEC CIK 0001825009) files insider reports with the SEC as Director of CalciMedica, Inc. (CALC) and Director of LENZ Therapeutics, Inc. (LENZ).

Signal8 holds 5 ownership filings by Guerard Frederic, all Form 4s, filed between Jun 11, 2025 and Oct 5, 2026. Those filings report 8 transactions, from Jun 11, 2025 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Guerard Frederic's filings is in LA JOLLA, CA.

Recent filings by Guerard Frederic

Oct 1, 2026: Grant or award of CALC derivative securities (Form 4, code A).
Aug 19, 2026: Grant or award of CALC derivative securities (Form 4, code A).
Jun 15, 2026: Grant or award of LENZ derivative securities (Form 4, code A).
Jun 24, 2025: Grants or awards of CALC derivative securities (4 lines, Form 4, code A).
Jun 11, 2025: Grant or award of LENZ derivative securities (Form 4, code A).

Other insiders filing for CalciMedica, Inc. (CALC)

Glicklich Alan, Director
Zaytsev Evgeny, Director
Shaw Allan, Director
WILSON ROBERT N, Director
Hebbar Sudarshan, Chief Medical Officer
Stauderman Kenneth A., Chief Scientific Officer

How to read Form 4 transaction codes